Literature DB >> 25641863

Viewpoint: model selection uncertainty, pre-specification, and model averaging.

Björn Bornkamp1.   

Abstract

Scientific progress in all empirical sciences relies on selecting models and performing inferences from selected models. Standard statistical properties (e.g., repeated sampling coverage probability of confidence intervals) cannot be guaranteed after a model selection. This viewpoint reviews this dilemma, puts the role that pre-specification can play into perspective and illustrates model averaging as a way to relax the problem of model selection uncertainty.
Copyright © 2015 John Wiley & Sons, Ltd.

Keywords:  dose-response, modelling

Mesh:

Substances:

Year:  2015        PMID: 25641863     DOI: 10.1002/pst.1671

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  3 in total

1.  Estimation of QT interval prolongation through model-averaging.

Authors:  Peter L Bonate
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-04-18       Impact factor: 2.745

2.  Optimal designs for frequentist model averaging.

Authors:  K Alhorn; K Schorning; H Dette
Journal:  Biometrika       Date:  2019-07-13       Impact factor: 3.028

3.  Mathematical Modeling of "Chronic" Infectious Diseases: Unpacking the Black Box.

Authors:  Anthony T Fojo; Emily A Kendall; Parastu Kasaie; Sourya Shrestha; Thomas A Louis; David W Dowdy
Journal:  Open Forum Infect Dis       Date:  2017-08-14       Impact factor: 4.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.